Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis

被引:14
作者
Kristt, D. [1 ,2 ]
Gesundheit, B. [3 ]
Stein, J. [4 ]
Shapira, M. Y. [3 ]
Or, R. [3 ]
Amar, A. [5 ]
Yaniv, I. [4 ]
Garty, B. [4 ]
Itah, R. [2 ]
Israeli, M. [1 ]
Klein, T. [1 ]
机构
[1] Rabin Med Ctr, Lab Immunogenet & Histocompatibil, Petah Tiqwa, Bhy, Israel
[2] Rabin Med Ctr, Mol Pathol Unit, Petah Tiqwa, Bhy, Israel
[3] Hadassah Hebrew Univ MC, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel
[4] Schneider Childrens MC, BMT Unit, Petah Tiqwa, Israel
[5] Lab Immunogenet & Histocompatibil, Jerusalem, Israel
关键词
chimerism; double chimerism; stem cell transplantation; double cord blood transplants; chimerism monitoring; STRs; STEM-CELL TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; SHORT TANDEM REPEAT; PCR AMPLIFICATION; CAPILLARY-ELECTROPHORESIS; MICROSATELLITE MARKERS; FLUORESCENCE DETECTION; MIXED CHIMERISM; ENGRAFTMENT KINETICS; MICROCHIMERISM;
D O I
10.1038/bmt.2009.120
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
Despite therapeutic advantages, double-donor (DD) HSCTs present technical problems for molecular chimerism (CHM) monitoring. These DD chimeras contain three matched DNAs, so that the genomes of donor(s) and recipient often share the same alleles. In the STR assay, shared recipient/donor alleles are common and have identical physico-chemical properties. As a consequence of the latter, they co-migrate in the same band ('shared peak'), which prevents measuring each allele separately. Without individual allelic measurements, the direct calculation of the chimeric recipient/donor DNA ratio is precluded. This is the first study to document and systematically examine these problems. Its goal was to provide a validated framework for accurate, routine monitoring based on a stepwise analytic paradigm for approximating percent CHM (%CHM) from shared STR-alleles. Analysis of STR-DNA from DD loci showed that at least four of six alleles were typically shared. Despite such extensive allelic sharing, we show how simple arithmetic procedures can be applied for standardized calculation of %CHM based on peak measurements. Criteria for selecting loci suitable for such analysis are provided. Validation of the computational results required analyzing 18 'informative' loci with pre-established reference values for %CHM. In all cases, the results for %CHM, calculated from peak measurements, were +/-5% of the reference value. The conclusions of the study are as follows: (1) Multi-donor chimeras, with shared alleles, can be accurately and simply analyzed within the usual limits of STR measurement error; (2) by examining these various facets of DD CHM analysis, this novel study has provided a basis for standardized, routine quantitative monitoring using the STR/VNTR assay. Bone Marrow Transplantation (2010) 45, 137-147; doi: 10.1038/bmt.2009.120; published online 8 June 2009
引用
收藏
页码:137 / 147
页数:11
相关论文
共 49 条
[1]
Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection:: the Paris-Robert!Debre experience [J].
Acquaviva, C ;
Duval, M ;
Mirebeau, D ;
Bertin, R ;
Cavé, H .
LEUKEMIA, 2003, 17 (01) :241-246
[2]
Microchimerism - An investigative frontier in autoimmunity and transplantation [J].
Adams, KM ;
Nelson, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1127-1131
[3]
[Anonymous], 2001, LEUKEMIA, V15, P303
[4]
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings [J].
Antin, JH ;
Childs, R ;
Filipovich, AH ;
Giralt, S ;
Mackinnon, S ;
Spitzer, T ;
Weisdorf, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (09) :473-485
[5]
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT [J].
Bader, P ;
Beck, J ;
Frey, A ;
Schlegel, PG ;
Hebarth, H ;
Handgretinger, R ;
Einsele, H ;
Niemeyer, C ;
Benda, N ;
Faul, C ;
Kanz, L ;
Niethammer, D ;
Klingebiel, T .
BONE MARROW TRANSPLANTATION, 1998, 21 (05) :487-495
[6]
How and when should we monitor chimerism after allogeneic stem cell transplantation? [J].
Bader, P ;
Niethammer, D ;
Willasch, A ;
Kreyenberg, H ;
Klingebiel, T .
BONE MARROW TRANSPLANTATION, 2005, 35 (02) :107-119
[7]
Double unrelated reduced-intensity umbilical cord blood transplantation in adults [J].
Ballen, Karen K. ;
Spitzer, Thomas R. ;
Yeap, Beow Y. ;
McAfee, Steven ;
Dey, Bimalangshu R. ;
Attar, Eyal ;
Haspel, Richard ;
Kao, Grace ;
Liney, Deborah ;
Alyea, Edwin ;
Lee, Stephanie ;
Cutler, Corey ;
Ho, Vincent ;
Soiffer, Robert ;
Antin, Joseph H. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) :82-89
[8]
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy [J].
Barker, JN ;
Weisdorf, DJ ;
DeFor, TE ;
Blazar, BR ;
McGlave, PB ;
Miller, JS ;
Verfaillie, CM ;
Wagner, JE .
BLOOD, 2005, 105 (03) :1343-1347
[9]
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning [J].
Baron, F ;
Baker, JE ;
Storb, R ;
Gooley, TA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Heimfeld, S ;
Oparin, D ;
Zellmer, E ;
Radich, JP ;
Grumet, FC ;
Blume, KG ;
Chauncey, TR ;
Little, MT .
BLOOD, 2004, 104 (08) :2254-2262
[10]
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease [J].
Brunstein, Claudio G. ;
Barker, Juliet N. ;
Weisdorf, Daniel J. ;
DeFor, Todd E. ;
Miller, Jeffrey S. ;
Blazar, Bruce R. ;
McGlave, Philip B. ;
Wagner, John E. .
BLOOD, 2007, 110 (08) :3064-3070